Identification of a monocyte phagocytic defect in a subpopulation of patients with nephritis. Experimental studies have demonstrated the cardinal role played by the mononuclear phagocyte system in the removal of antigen-antibody complexes. To assess the functional capacity of phagocytes in patients with renal disease, 33 normal subjects, 10 patients with mesangial proliferative glomerulonephritis. 8 patients with membranous nephropathy, and 8 patients with moderately severe chronic renal failure were studied by an in vitro assay, measuring the ability of isolated monocytes to ingest sheep erythrocytes coated with IgG antibody and to phagocytize latex beads. Monocytes from four The deposition of soluble complexes in the glomerulus is one of the major mechanisms leading to the development of nephritis. There are at least two critical factors which influence the genesis of immune complex nephritis: the induction of an antibody response which is suboptimal and allows the formation of immune complexes in antigen excess and the functional capacity of the mononuclear phagocyte system to take up and process antigen-antibody complexes via its Fc receptor. Early studies have shown that when preformed immune complexes were infused into the circulation, the bulk of such complexes was sequestered in the phagocyte systems of the liver and 851 spleen [1]; furthermore, it also showed that the system was subject to saturation [2] , and that if complexes were modified by physicochemical means such that the uptake was diminished, increased renal deposition would result [3, 4] . The converse has also been shown, that if the functional capacity of the system was stimulated by the administration of agents such as Corynebacterium parvum or zymosan to the host, there would be reduced deposition of these macromolecules in the glomeruli, due to an augmented uptake and degradation of the substances by the hepatic and splenic phagocytes [5, 6] . In animal models such as in mice injected with lymphochoriocytic menningitis virus [71, there was evidence of depressed phagocytic activity and presumed facilitated deposition of immune complexes in the kidney. The data in regard to the animal analogue of lupus nephritis, Fl NZBINZW female mice, are conflicting in this regard [8-101. While some investigators were able to define the presence of defective uptake of complexes, this has not been confirmed by others [8] [9] [10] . The most current study showed that while there may be no difference between normal mice and the Fl NZB/NZW Fl hybrids in terms of the uptake of immune complexes, the complexes bound to the surfaces of phagocytes of Fl NZB/NZW hybrids were more readily displaced [11] . There is convincing evidence of a defect in Fc receptor function in human patients with systemic lupus erythematous (SLE) when they were examined by in vivo techniques measuring the clearance of radiolabeled complexes [12]. Subpopulations of patients with nephritis examined by similar techniques were also found to have a defect in Fc receptor function [13, 14] . We wish to report in this communication the identification of a subpopulation of patients with nephritis who have a demonstrable defect in Fc receptor function by means of an in vitro assay.
membranous nephropathy, and 8 patients with moderately severe chronic renal failure were studied by an in vitro assay, measuring the ability of isolated monocytes to ingest sheep erythrocytes coated with IgG antibody and to phagocytize latex beads. Monocytes from four patients with mesangial proliferative glomerulonephritis and one patient with membranous nephropathy exhibited a subnormal capacity to ingest the antibody-coated erythrocytes. Additionally, monocytes from two of the four patients with mesangial proliferative glomerulonephritis and a defect in ingesting sensitized erythrocytes had a subnormal capacity to phagocytize latex beads. The results are interpreted in the context of a hypothesis which suggests that patients with immune nephritis show various forms of immune deficit.
Identification d'un défaut de phagocytose monocytaire dans une souspopulation de malades avec néphrite. Des etudes expérimentales ont démontré le role capital jouè par le système phagocytaire mononucléaire dans l'élimination des complexes antigènes-anticorps. Afin d'évaluer Ia capacité fonctionnelle des phagocytes chez des malades ayant une maladie rénale, 33 sujets normaux, 10 The deposition of soluble complexes in the glomerulus is one of the major mechanisms leading to the development of nephritis. There are at least two critical factors which influence the genesis of immune complex nephritis: the induction of an antibody response which is suboptimal and allows the formation of immune complexes in antigen excess and the functional capacity of the mononuclear phagocyte system to take up and process antigen-antibody complexes via its Fc receptor. Early studies have shown that when preformed immune complexes were infused into the circulation, the bulk of such complexes was sequestered in the phagocyte systems of the liver and 851 spleen [1]; furthermore, it also showed that the system was subject to saturation [2] , and that if complexes were modified by physicochemical means such that the uptake was diminished, increased renal deposition would result [3, 4] . The converse has also been shown, that if the functional capacity of the system was stimulated by the administration of agents such as Corynebacterium parvum or zymosan to the host, there would be reduced deposition of these macromolecules in the glomeruli, due to an augmented uptake and degradation of the substances by the hepatic and splenic phagocytes [5, 6] . In animal models such as in mice injected with lymphochoriocytic menningitis virus [71, there was evidence of depressed phagocytic activity and presumed facilitated deposition of immune complexes in the kidney. The data in regard to the animal analogue of lupus nephritis, Fl NZBINZW female mice, are conflicting in this regard [8-101. While some investigators were able to define the presence of defective uptake of complexes, this has not been confirmed by others [8] [9] [10] . The most current study showed that while there may be no difference between normal mice and the Fl NZB/NZW Fl hybrids in terms of the uptake of immune complexes, the complexes bound to the surfaces of phagocytes of Fl NZB/NZW hybrids were more readily displaced [11] . There is convincing evidence of a defect in Fc receptor function in human patients with systemic lupus erythematous (SLE) when they were examined by in vivo techniques measuring the clearance of radiolabeled complexes [12] . Subpopulations of patients with nephritis examined by similar techniques were also found to have a defect in Fc receptor function [13, 14] . We wish to report in this communication the identification of a subpopulation of patients with nephritis who have a demonstrable defect in Fc receptor function by means of an in vitro assay.
Methods
The following subjects were studied: 33 healthy subjects, 10 patients with mesangial proliferative glomerulonephritis, 8 patients with membranous nephropathy, and 8 patients with moderate to severe chronic renal failure from non-immune'
causes. All patients with mesangial proliferative glomerulonephritis and membranous nephropathy had renal biopsies with tissue studies by light, fluorescence, and electronmicroscopy. counted in a hemocytometer. Monocyte monolayers were prepared by layering thoroughly cleaned circular glass cover slips (15 mm diameter, SGA Scientific, Inc., Bloomfield, New Jersey) with 0.25 ml of a suspension of mononuclear cells (adjusted to a concentration of 2.2 x 106 cells/mi with RPMI-BSA medium). The cells were incubated at 37°C >< 60 mm in a 5% CO2 humidified atmosphere, followed by rinsing to remove nonadherent cells. Adherent cells were defined by morphology and the esterase stain and were greater than 95% monocytes. Sheep erythrocytes (E) were obtained, stored in veronal-buffered saline, pH 7.5 containing 0.1% gelatin, and 0.04 M EDTA. Erythrocytes coated with IgG antibody (EAIgG) were prepared by incubating 1 x i09 sheep erythrocytes with an equal volume of rabbit antisheep hemolysin (Cordis Laboratories, Miami, Florida) for 30 mm at 37°C anti then 30 mm at 4°C, the titer of antisheep hemolysin was chosen as a subagglutinating titer and was approximately 1/100. Monolayers of monocytes were layered with 0.2 ml of the coated erythrocytes, incubated for 45 mm x 37°C in a CO2 chamber, and then rinsed twice with HBSS. Washed monoiayers were treated with a pulse of distilled water to lyse noningested erythrocytes, rinsed in medium, fixed with 2.5% glutaraldehyde, washed again, and stained with 4% Giemsa solution, air-dried and mounted on microscope slides. The number of monocytes ingesting one or more particles was counted by examining at least 400 monocytes. Triplicates were done for each subject.
Latex bead phagocytosis was assessed by a similar protocol except that the monocyte monolayers were overlaid with latex beads (Dow Chemical Co., Indianapolis, Indiana), and phagocytosis was assessed by phase contrast microscopy.
Circulating immune complexes were assayed by the solid phase Clq-assay [17] ; reagents were prepared as reported from our previous studies using the Clq-binding assay [18] . Sera from the five patients with the Fe receptor defect were assayed for serum immune complexes by the Raji cell assay [19] Figure 1 . In normal subjects the mean (± SD) percentage of monocytes exhibiting phagocytosis of EAIgG particles was 89% 5%.
Monocytes of patients with chronic renal failure showed a normal capacity to ingest antibody-coated erythrocytes. The monocytes of only one of the eight patients with mernhranous nephropathy showed a subnormal phagocytic capacity. By comparison, monocytes of four of the ten patients with mesangial proliferative glomerulonephritis exhibited a depressed ahi Iity to ingest EAIgG particles. The calculated mean (± SD) percentages of monocytes exhibiting phagocytosis of sensitized erythrocytes for the normal subjects, patients with mesangial proliferative glomerulonephritis, membranous nephropathy, and chronic renal failure were 89% + 5%, 72% 17%, 87% 8%, and 90% 6%, respectively. Statistical analysis by Student's t test showed a significant difference between the mean percentage from patients with mesangial proliferative glomerulonephritis and the mean percentages of normal subjects (t = 3.10, P < 0.01), patients with membranous nephropathy (t -2.43, P < 0.02), and with chronic renal failure (t -3.04, P < 0.01). However, if the comparisons were made between the mean of the six patients with mesangial proliferative glomerulonephritis without the monocyte phagocytic defect and the means of the other three groups, the differences were no longer The results of the assay for latex bead phagocytosis are shown in Figure 2 . In normal subjects the mean (± SD) percentage of monocytes exhibiting phagocytosis of latex beads was 89% 4%. Monocytes from two of the patients with mesangial proliferative glomerulonephritis who had an Fc receptor defect also had a subnormal ability to ingest latex beads (Table 1 ). There were no statistical differences observed between the means of the groups of subjects studied.
The clinical characteristics of the five patients with the phagocytic defect are shown in Table 1 with a comparison of the characteristics of the other patients with various forms of chronic renal failure or the nephrotic syndrome. No differences were discernible between the group with the defect and the patient controls, except that the single patient with membranous nephropathy exhibiting the phagocytic defect had the lowest serum albumin concentration of all patients studied.
Discussion
The data in this study clearly show that a subpopulation of patients with nephritis have a defect in monocyte Fc receptor function as demonstrated by an in vitro technique monitoring the capacity of these cells to ingest sheep erythrocytes coated with IgG antibody. Four of the ten patients with mesangial proliferative glomerulonephritis exhibited this defect. Additionally, a defect in phagocytizing latex beads was detected in two of these four patients. By comparison, only one of the eight patients with membranous nephropathy had a demonstrable monocyte phagocytic defect.
The reasons for these phagocytic defects are unclear. In one patient with mesangial proliferative glomerulonephritis, the presence of immune complexes in the sera could be responsible by occupying Fc receptor sites. Comparison studies with patients exhibiting the nephrotic syndrome due to membranous nephropathy (in the group with normal Fc receptor function) exclude protein depletion as a cause since comparable serum albumin levels were observed in both groups. This is underlined by the fact that the patient with membranous nephropathy who had a severely lowered serum albumin had only a marginal Fc receptor defect. Furthermore, the defect could not be induced by incubating normal monocytes with nephrotic sera. Similarly, uremia could be excluded as a contributing cause from a study of monocyte phagocyte function of uremic subjects.
The significance of these observations relate to the role of the mononuclear phagocyte system in the genesis of nephritis. An Fc receptor defect in the mononuclear phagocyte system would more readily allow the saturation of this system by antigenantibody complexes with overflow into the kidney. Experimental studies have also shown an important function of the monocyte/macrophage in the local removal of such complexes, such that an impairment of the Fc receptor would allow the persistence of these tissue deposits [20] . It is attractive to speculate that the differential expression of immune complex nephritis as exemplified by mernbranous nephropathy and mesangial proliferative glomerulonephritis may at least in part be due to the functional status of the monocyte Fc receptor.
Since a substantial proportion of patients with mesangial proliferative glomerulonephritis do not have such a demonstrable defect, other factors must also be involved.
The identification of a subpopulation of patients with a monocyte phagocytic defect also brings into focus the continued substantiation of the hypothesis proposed by Peters and Lachmann that nephritis may occur in states of immune deficiency [21] . There are now several areas of evidence to support [23] and recent investigations have shown a relationship between activity of nephritis and this complement function [24] . In addition to complement deficiency in nephritis, studies in our laboratory have shown that patients with membranous nephropathy have an in vitro defect of immunoglobulin synthesis on stimulation of their peripheral blood lymphocytes by the polyclonal activator, pokeweed mitogen, and that the defect is mediated by a population of monocyte-suppressor cells [25] . These observations are indirectly corroborated by the report of Carney et al [261 who found that a substantial population of patients with nephritis generate a reduced antibody response to tetanus toxoid as compared to controls. In addition, other functional lymphocyte abnormalities, such as the response of these cells to phytohemagglutinin, were also discovered. It is in this context that our finding of a subpopulation of patients with a monocyte Fc receptor defect must be interpreted. This subpopulation may represent a segment of patients in the continuum of patients with a variety of immune deficiencies.
